Glenmark expects generics to drive growth over next 3 yrs Ruby Khatun Khatun25 Sep 2017 5:07 AM GMTMumbai: Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected...
Glenmark gets USFDA nod for chest pain tablets Ruby Khatun Khatun22 Sep 2017 5:17 AM GMTNew Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
Glenmark looks to file up to 25 product applications annually Ruby Khatun Khatun19 Sep 2017 4:49 AM GMTNew Delhi: Glenmark Pharmaceuticals plans to file close to 25 product applications annually over the next five years, the company's chairman has...
Glenmark gets USFDA approval for Rythmol SR generic Ruby Khatun Khatun13 Sep 2017 8:38 AM GMTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...